The effect of KU 60019 and NU 7026 on the sensitivity of OVCA429/pCEG and OVCA429/NICD3 cells to MSeA and carboplatin co-treatment.

Abstract

<p>Cells were treated with MSeA and a gradient of carboplatin (<i>A</i>–<i>D</i>) or carboplatin and a gradient concentration of MSeA (<i>E</i>–<i>H</i>) in the presence or absence of KU 60019 (<i>A</i>, <i>B</i>, <i>E</i>, <i>F</i>) and NU 7026 (<i>C</i>, <i>D</i>, <i>G</i>, <i>H</i>). Cell viability was determined by SRB assay. Values are mean ± S.E.M. (n  =  3).</p